{"name": "Cytopia",
 "permalink": "cytopia",
 "crunchbase_url": "http://www.crunchbase.com/company/cytopia",
 "homepage_url": "http://www.cytopia.com.au",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "cytopia@cytopia.com.au",
 "phone_number": "61-3-9208-4222",
 "description": "",
 "created_at": "Thu Oct 08 12:07:07 UTC 2009",
 "updated_at": "Thu Oct 08 12:14:41 UTC 2009",
 "overview": "\u003Cp\u003ECytopia\u0026#8217;s mission is to develop targeted small molecule therapeutics for cancer. The company also aims to develop drugs for other diseases with unmet medical need including immune conditions, such as organ transplant rejection. Through its internal discovery and development expertise, Cytopia has devised a portfolio of drug candidates at various stages of formal development.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       62],
      "assets/images/resized/0006/2090/62090v1-max-150x150.jpg"],
     [[191,
       79],
      "assets/images/resized/0006/2090/62090v1-max-250x250.jpg"],
     [[191,
       79],
      "assets/images/resized/0006/2090/62090v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.fiercebiotech.com/story/ym-biosciences-inks-deal-acquire-cytopia/2009-10-06?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
   "source_description": "YM BioSciences inks deal to acquire Cytopia",
   "acquired_year": 2009,
   "acquired_month": 10,
   "acquired_day": 6,
   "acquiring_company":
    {"name": "YM BioSciences",
     "permalink": "ym-biosciences",
     "image":
      {"available_sizes":
        [[[150,
           30],
          "assets/images/resized/0006/2086/62086v1-max-150x150.jpg"],
         [[250,
           51],
          "assets/images/resized/0006/2086/62086v1-max-250x250.jpg"],
         [[312,
           64],
          "assets/images/resized/0006/2086/62086v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "576 Swan Street ",
    "address2": "Richmond Victoria 3121",
    "zip_code": "",
    "city": "",
    "state_code": null,
    "country_code": "AUS",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        100],
       "assets/images/resized/0006/2091/62091v1-max-150x150.jpg"],
      [[250,
        167],
       "assets/images/resized/0006/2091/62091v1-max-250x250.jpg"],
      [[450,
        301],
       "assets/images/resized/0006/2091/62091v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}